Powles, T ; Burotto, M ; Escudier, B...
Powles , T , Burotto , M , Escudier , B , Apolo , A B , Bourlon , M T , Shah , A Y , Suárez , C , Porta , C , Barrios , C H , Richardet , M , Gurney , H , Kessler , E R , Tomita , Y , Bedke , J , George , S , Scheffold , C , Wang , P , Fedorov , V , Motzer , R J & Choueiri , T K 2024 , ' Nivolumab plus cabozantinib versus sunitinib for first-line treatment of advanced renal cell carcinoma : extended follow-up from the phase III randomised CheckMate 9ER trial ' , ESMO Open , vol. 9 , no. 5 , 102994 , pp. 1-11 . https://doi.org/10.1016/j.esmoop.2024.102994.  , 2024

Bedke, J ; Choueiri, T ; Powles, T...
http://dx.doi.org/10.3205/21swdgu23.  , 2021

Choueiri, T. K ; Larkin, J ; Pal, S...
http://eprints.gla.ac.uk/241286/1/241286.pdf.  , 2021

Choueiri, T. K ; Motzer, R. J ; Rini, B. I...
Choueiri , T K , Motzer , R J , Rini , B I , Haanen , J , Campbell , M T , Venugopal , B , Kollmannsberger , C , Gravis-Mescam , G , Uemura , M , Lee , J L , Grimm , M O , Gurney , H , Schmidinger , M , Larkin , J , Atkins , M B , Pal , S K , Wang , J , Mariani , M , Krishnaswami , S , Cislo , P , Chudnovsky , A , Fowst , C , Huang , B , di Pietro , A & Albiges , L 2020 , ' Updated efficacy results from the JAVELIN Renal 101 trial : first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma ' , Annals of Oncology , vol. 31 , no. 8 , pp. 1030-1039 . https://doi.org/10.1016/j.annonc.2020.04.010.  , 2020

Choueiri, T.K ; Powles, T ; Burotto, M...
http://eprints.uanl.mx/22445/1/22445.pdf.  , 2020

Choueiri, T K ; Motzer, R J ; Rini, B I...
https://eprints.gla.ac.uk/284663/1/284663.pdf.  , 2020

Grunwald V ; Powles T ; Choueiri T. K...
info:eu-repo/semantics/altIdentifier/pmid/30689402.  , 2019

Motzer R. J ; Rini B. I ; McDermott D. F...
info:eu-repo/semantics/altIdentifier/pmid/31427204.  , 2019

Sternberg C. N ; Motzer R. J ; Hutson T. E...
info:eu-repo/semantics/altIdentifier/pmid/31601514.  , 2019

Rini, B. I ; Tannir, N. M ; Escudier, B...
Rini , B I , Tannir , N M , Escudier , B , McDermott , D F , Grimm , M O , Porta , C , Powles , T , Kollmannsberger , C K , Gurney , H P , Tykodi , S S , Harrison , M , Heng , D Y C , Grünwald , V , Choueiri , T K , Mekan , S , McHenry , M B , Hammers , H J , Motzer , R J & George , S 2018 , ' Characterization of response to nivolumab plus ipilimumab (N+I) or sunitinib (S) in patients (Pts) with previously untreated advanced renal cell carcinoma (arcc) : Checkmate 214 ' , Annals of Oncology , vol. 29 , no. Supplement 8 , pp. viii309-viii310 . https://doi.org/10.1093/annonc/mdy283.084.  , 2018

Motzer R. J ; Tannir N. M ; McDermott D. F...
info:eu-repo/semantics/altIdentifier/pmid/29562145.  , 2018

Tannir N. M ; Figlin R. A ; Gore M. E...
info:eu-repo/semantics/altIdentifier/pmid/28711490.  , 2018

Schönheit, J ; Powles, T ; Tannir, N...
Hanna N, Sun M, Meyer CP, Nguyen PL, Pal SK, Chang SL, de Velasco G, Trinh QD, Choueiri TK. Survival Analyses of Patients With Metastatic Renal Cancer Treated With Targeted Therapy With or Without Cytoreductive Nephrectomy: A National Cancer Data Base Study. J Clin Oncol. 2016 Sep;34(27):3267-75. DOI:10.1200/JCO.2016.66.7931.  , 2018

Guo, J ; Jin, J ; Oya, M...
issn:1756-8722.  , 2018

Motzer, R. J ; Penkov, K ; Haanen, J. B. A. G...
Motzer , R J , Penkov , K , Haanen , J B A G , Rini , B I , Albiges , L , Campbell , M T , Kollmannsberger , C K , Negrier , S , Uemura , M , Lee , J L , Gurney , H , Berger , R , Schmidinger , M , Larkin , J , Atkins , M B , Wang , J , Robbins , P B , Chudnovsky , A , Di Pietro , A & Choueiri , T K 2018 , ' JAVELIN renal 101 : a randomized, phase III study of avelumab + axitinib vs sunitinib as first-line treatment of advanced renal cell carcinoma (aRCC) ' , Annals of Oncology , vol. 29 , no. Supplement 8 , pp. viii724 . https://doi.org/10.1093/annonc/mdy424.036.  , 2018